Myriad Genetics, Inc. provided earnings guidance for the Fourth Quarter and Full Year 2025 and 2026. For the quarter, revenues to be between $207 million and $209 million.

For the full-year 2025 revenues to be between $822 million and $824 million.

For the full year 2026, revenue to be between $860 million and $880 million.